A Study of the Safety and Pharmacology of SGN-40 Administered in Combination With Bortezomib in Patients With Relapsed or Refractory Multiple Myeloma

Clinical Trial ID NCT00664898

PubWeight™ 3.66^‹?›

🔗 Visit the ClinicalTrials.gov page for NCT00664898

Top papers